Gemphire Therapeutics Inc Banner Image

Gemphire Therapeutics Inc has reached its limit for free report views

Work for Gemphire Therapeutics Inc? Upgrade Your Profile and unlock all your annual reports.

Gemphire Therapeutics Inc

  • Ticker GEMP
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Gemphire Therapeutics Inc Logo Image
  • 11-50 Employees
  • Based in Livonia, Michigan
Gemphire is a clinical-stage biopharmaceutical company that is committed to helping patients with cardiometabolic disorders, including dyslipidemia and NASH. They are focused on providing new treatment options for cardiometabolic diseases through there complementary, convenient, cost-effective product candidate gemcabene as add-on to the standard of care especially statins that will benefitMore patients, physicians, and payors.
Gemphire Therapeutics Inc

Most Recent Annual Report

Gemphire Therapeutics Inc MOST RECENT 2019 Annual Report

Report Locked. Gemphire Therapeutics Inc has reached its limit for free report views.

Older/Archived Annual Reports